AAPL278.40-14.77 (-5.04%) ▼|ABBV240.35+5.46 (+2.32%) ▲|ABT93.75+3.26 (+3.60%) ▲|ACN129.67+0.52 (+0.40%) ▲|ADBE197.79+1.24 (+0.63%) ▲|AMAT620.57+31.61 (+5.37%) ▲|AMD514.99-4.07 (-0.78%) ▼|AMGN358.09+6.70 (+1.91%) ▲|AMT170.43-4.03 (-2.31%) ▼|AMZN227.80-6.57 (-2.80%) ▼|AVGO377.39-4.69 (-1.23%) ▼|AXP350.47+7.91 (+2.31%) ▲|BA222.30+2.05 (+0.93%) ▲|BAC58.69+0.96 (+1.66%) ▲|BKNG180.47-0.81 (-0.44%) ▼|BLK994.37+11.77 (+1.20%) ▲|BMY56.05+1.05 (+1.91%) ▲|BNY146.20+2.64 (+1.84%) ▲|BRK-B494.26-0.55 (-0.11%) ▼|C146.50+2.91 (+2.03%) ▲|CAT1,039.05+44.60 (+4.48%) ▲|CL92.05+0.17 (+0.19%) ▲|CMCSA22.96+0.32 (+1.41%) ▲|COF207.97+7.49 (+3.74%) ▲|COP106.57-0.35 (-0.33%) ▼|COST952.59-8.38 (-0.87%) ▼|CRM153.24+0.48 (+0.31%) ▲|CSCO118.92-0.82 (-0.68%) ▼|CVS104.33+2.46 (+2.41%) ▲|CVX171.22-0.23 (-0.13%) ▼|DE618.32+17.57 (+2.92%) ▲|DHR196.17+7.30 (+3.87%) ▲|DIS101.21+0.09 (+0.08%) ▲|DUK127.67+1.14 (+0.90%) ▲|EMR146.42+4.98 (+3.52%) ▲|FDX323.95+7.12 (+2.25%) ▲|GD351.13+6.81 (+1.98%) ▲|GE375.20+9.32 (+2.55%) ▲|GEV1,063.94+6.29 (+0.59%) ▲|GILD126.51+1.36 (+1.09%) ▲|GM79.14+0.19 (+0.23%) ▲|GOOG339.31-5.72 (-1.66%) ▼|GOOGL339.38-5.90 (-1.71%) ▼|GS1,086.18+9.27 (+0.86%) ▲|HD346.32+3.46 (+1.01%) ▲|HON235.52+8.10 (+3.56%) ▲|IBM262.19-0.77 (-0.29%) ▼|INTC128.77-3.14 (-2.38%) ▼|INTU260.40-1.93 (-0.74%) ▼|ISRG410.00+8.17 (+2.03%) ▲|JNJ247.68+6.68 (+2.77%) ▲|JPM340.53+7.08 (+2.12%) ▲|KO80.91+0.31 (+0.38%) ▲|LIN524.44+8.71 (+1.69%) ▲|LLY1,126.55+9.29 (+0.83%) ▲|LMT510.67+19.03 (+3.87%) ▲|LOW224.61+3.16 (+1.43%) ▲|LRCX376.29+1.47 (+0.39%) ▲|MA502.27+7.86 (+1.59%) ▲|MCD268.81-5.08 (-1.85%) ▼|MDLZ62.72+0.98 (+1.58%) ▲|MDT82.00+1.87 (+2.33%) ▲|META551.09-6.71 (-1.20%) ▼|MMM168.69+2.78 (+1.68%) ▲|MO73.06+0.99 (+1.37%) ▲|MRK123.80+3.20 (+2.65%) ▲|MS224.69+4.83 (+2.19%) ▲|MSFT358.46-6.99 (-1.91%) ▼|MU1,152.28+104.36 (+9.96%) ▲|NEE88.07+0.45 (+0.51%) ▲|NFLX72.66+0.81 (+1.13%) ▲|NKE41.69-0.14 (-0.32%) ▼|NOW91.13-2.68 (-2.85%) ▼|NVDA193.66-5.25 (-2.64%) ▼|ORCL152.55-4.98 (-3.16%) ▼|PEP141.88-0.39 (-0.27%) ▼|PFE24.23+0.19 (+0.80%) ▲|PG150.24-1.80 (-1.18%) ▼|PLTR107.23-6.28 (-5.53%) ▼|PM179.81+2.50 (+1.41%) ▲|QCOM205.97+8.64 (+4.38%) ▲|RTX188.85+3.79 (+2.05%) ▲|SBUX103.98+0.46 (+0.44%) ▲|SCHW92.20+0.81 (+0.89%) ▲|SO96.66+0.88 (+0.92%) ▲|SPG223.87+1.72 (+0.77%) ▲|T22.59+0.22 (+0.98%) ▲|TMO512.18+19.98 (+4.06%) ▲|TMUS182.78+1.99 (+1.10%) ▲|TSLA375.46-0.01 (0.00%) ▼|TXN308.52+5.41 (+1.78%) ▲|UBER73.24-0.61 (-0.83%) ▼|UNH415.71+9.91 (+2.44%) ▲|UNP266.50+6.54 (+2.52%) ▲|UPS108.65+2.51 (+2.36%) ▲|USB61.50+1.39 (+2.31%) ▲|V338.04+5.81 (+1.75%) ▲|VZ46.06+0.38 (+0.82%) ▲|WFC85.84+1.54 (+1.83%) ▲|WMT118.01-1.00 (-0.84%) ▼|XOM137.22+0.32 (+0.23%) ▲|AAPL278.40-14.77 (-5.04%) ▼|ABBV240.35+5.46 (+2.32%) ▲|ABT93.75+3.26 (+3.60%) ▲|ACN129.67+0.52 (+0.40%) ▲|ADBE197.79+1.24 (+0.63%) ▲|AMAT620.57+31.61 (+5.37%) ▲|AMD514.99-4.07 (-0.78%) ▼|AMGN358.09+6.70 (+1.91%) ▲|AMT170.43-4.03 (-2.31%) ▼|AMZN227.80-6.57 (-2.80%) ▼|AVGO377.39-4.69 (-1.23%) ▼|AXP350.47+7.91 (+2.31%) ▲|BA222.30+2.05 (+0.93%) ▲|BAC58.69+0.96 (+1.66%) ▲|BKNG180.47-0.81 (-0.44%) ▼|BLK994.37+11.77 (+1.20%) ▲|BMY56.05+1.05 (+1.91%) ▲|BNY146.20+2.64 (+1.84%) ▲|BRK-B494.26-0.55 (-0.11%) ▼|C146.50+2.91 (+2.03%) ▲|CAT1,039.05+44.60 (+4.48%) ▲|CL92.05+0.17 (+0.19%) ▲|CMCSA22.96+0.32 (+1.41%) ▲|COF207.97+7.49 (+3.74%) ▲|COP106.57-0.35 (-0.33%) ▼|COST952.59-8.38 (-0.87%) ▼|CRM153.24+0.48 (+0.31%) ▲|CSCO118.92-0.82 (-0.68%) ▼|CVS104.33+2.46 (+2.41%) ▲|CVX171.22-0.23 (-0.13%) ▼|DE618.32+17.57 (+2.92%) ▲|DHR196.17+7.30 (+3.87%) ▲|DIS101.21+0.09 (+0.08%) ▲|DUK127.67+1.14 (+0.90%) ▲|EMR146.42+4.98 (+3.52%) ▲|FDX323.95+7.12 (+2.25%) ▲|GD351.13+6.81 (+1.98%) ▲|GE375.20+9.32 (+2.55%) ▲|GEV1,063.94+6.29 (+0.59%) ▲|GILD126.51+1.36 (+1.09%) ▲|GM79.14+0.19 (+0.23%) ▲|GOOG339.31-5.72 (-1.66%) ▼|GOOGL339.38-5.90 (-1.71%) ▼|GS1,086.18+9.27 (+0.86%) ▲|HD346.32+3.46 (+1.01%) ▲|HON235.52+8.10 (+3.56%) ▲|IBM262.19-0.77 (-0.29%) ▼|INTC128.77-3.14 (-2.38%) ▼|INTU260.40-1.93 (-0.74%) ▼|ISRG410.00+8.17 (+2.03%) ▲|JNJ247.68+6.68 (+2.77%) ▲|JPM340.53+7.08 (+2.12%) ▲|KO80.91+0.31 (+0.38%) ▲|LIN524.44+8.71 (+1.69%) ▲|LLY1,126.55+9.29 (+0.83%) ▲|LMT510.67+19.03 (+3.87%) ▲|LOW224.61+3.16 (+1.43%) ▲|LRCX376.29+1.47 (+0.39%) ▲|MA502.27+7.86 (+1.59%) ▲|MCD268.81-5.08 (-1.85%) ▼|MDLZ62.72+0.98 (+1.58%) ▲|MDT82.00+1.87 (+2.33%) ▲|META551.09-6.71 (-1.20%) ▼|MMM168.69+2.78 (+1.68%) ▲|MO73.06+0.99 (+1.37%) ▲|MRK123.80+3.20 (+2.65%) ▲|MS224.69+4.83 (+2.19%) ▲|MSFT358.46-6.99 (-1.91%) ▼|MU1,152.28+104.36 (+9.96%) ▲|NEE88.07+0.45 (+0.51%) ▲|NFLX72.66+0.81 (+1.13%) ▲|NKE41.69-0.14 (-0.32%) ▼|NOW91.13-2.68 (-2.85%) ▼|NVDA193.66-5.25 (-2.64%) ▼|ORCL152.55-4.98 (-3.16%) ▼|PEP141.88-0.39 (-0.27%) ▼|PFE24.23+0.19 (+0.80%) ▲|PG150.24-1.80 (-1.18%) ▼|PLTR107.23-6.28 (-5.53%) ▼|PM179.81+2.50 (+1.41%) ▲|QCOM205.97+8.64 (+4.38%) ▲|RTX188.85+3.79 (+2.05%) ▲|SBUX103.98+0.46 (+0.44%) ▲|SCHW92.20+0.81 (+0.89%) ▲|SO96.66+0.88 (+0.92%) ▲|SPG223.87+1.72 (+0.77%) ▲|T22.59+0.22 (+0.98%) ▲|TMO512.18+19.98 (+4.06%) ▲|TMUS182.78+1.99 (+1.10%) ▲|TSLA375.46-0.01 (0.00%) ▼|TXN308.52+5.41 (+1.78%) ▲|UBER73.24-0.61 (-0.83%) ▼|UNH415.71+9.91 (+2.44%) ▲|UNP266.50+6.54 (+2.52%) ▲|UPS108.65+2.51 (+2.36%) ▲|USB61.50+1.39 (+2.31%) ▲|V338.04+5.81 (+1.75%) ▲|VZ46.06+0.38 (+0.82%) ▲|WFC85.84+1.54 (+1.83%) ▲|WMT118.01-1.00 (-0.84%) ▼|XOM137.22+0.32 (+0.23%) ▲|
20.6 C
New York
Thursday, June 25, 2026

Tag: date

newssourceFORcompanyinformationcontent1marketreleases

HEC Group Opens First Overseas Flagship Store at Marina Bay Sands Singapore

HEC Life+ flagship store marks a major milestone in the company's global expansion and commitment to science-backed wellness innovationSINGAPORE, June 11, 2026 /PRNewswire/ --...

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Share Buyback Transaction Details June 4 – June 10, 2026

PRESS RELEASE                                        

Transaction in Own Shares

Transaction in Own Shares

Crédit Agricole Financement de l’Habitat SFH : EARLY REPURCHASE OF ISIN FR001400JM17

Montrouge, June 11, 2026

Regulatory release no. 4 – 2026: Correction. Result of InstallatørGruppen A/S’ Initial Public Offering on Nasdaq Copenhagen

                           

Regulatory release no. 3 – 2026: Stabilisation period begins

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results
and Provides Business Update

Glass House Brands Announces the Filing of Shelf Prospectus and At-The-Market Distribution Program

LONG BEACH, Calif. and TORONTO, June 10, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF) announced today that it has filed a short form base shelf prospectus (the “Shelf Prospectus”) dated June 10, 2026 with the securities regulatory authorities in all provinces and territories of Canada. The Shelf Prospectus replaces the Company’s prior short form base shelf prospectus, which was set to expire on June 17, 2026.

HORIZON PETROLEUM COMMENCES CIVIL WORKS AT THE LACHOWICE 7 WELLSITE IN POLAND

CALGARY, AB, June 10, 2026 /PRNewswire/ - Horizon Petroleum Ltd. ("Horizon" or the "Company") (TSXV: HPL) (FRA: HPM) (Tradegate: HPM) is pleased to announce the...

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an underwritten public offering of 47,619,048 shares of its common stock at a public offering price of $1.05 per share. The aggregate gross proceeds from this offering are expected to be $50 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about June 12, 2026, subject to the satisfaction of customary closing conditions. In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 7,142,857 shares of Humacyte’s common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being sold by Humacyte.

GlycoNex Announces Positive Topline Results for Phase III Clinical Trial of Denosumab Biosimilar SPD8

NEW TAIPEI CITY, June 10, 2026 /PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), today announced that the Phase III clinical trial...

EMP METALS CLOSES SECOND TRANCHE FINANCING

VANCOUVER, BC, June 10, 2026 /CNW/ - EMP Metals Corp. (CSE: EMPS) (OTCQB: EMPPF) ("EMP Metals" or the "Company") is pleased to announce that...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDate

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers